All posts by imreal

Advancements Series to Explore Improvements in Telehealth Connectivity


News Image

An upcoming segment of Advancements with Ted Danson will focus on recent innovations in telehealth technology.

With a look at certain disparities being felt throughout the healthcare industry, Advancements will explore the need for broadband and telehealth services today. Audiences will discover how the COVID-19 pandemic brought to light the severity of the digital divide in South Carolina, especially in rural and low-income communities.

Audiences will learn how Palmetto Care Connections’ (PCC) Digital Inclusion Solutions are helping to close the digital divide for residents in rural and underserved areas by increasing internet access and affordability, and by connecting individuals to quality-of-life resources through digital literacy trainings.

“Through our digital inclusion program, PCC has reached over 1,200 South Carolinians in rural and underserved communities in 14 Counties with some of the highest health disparities,” said Kathy Schwarting, chief executive officer of PCC. “Each program participant received in person digital literacy training with a telehealth and health literacy segment, a laptop or tablet, and assistance with affordable internet solutions.”

In addition, the show will explore how PCC’s Broadband Consortium helps eligible health care providers receive up to 65% savings on broadband, internet, and network equipment, connecting more people with vital care.

“PCC offers an array of technology and equipment solutions for implementing telehealth programs,” said Richard Lubin, senior producer for the Advancements series. “We look forward to sharing how PCC is helping to bring these solutions to patients in need.”

About Palmetto Care Connections:

Established in 2010, Palmetto Care Connections (PCC) is a non-profit organization that provides technology, broadband, and telehealth solutions in rural and underserved areas in South Carolina in an effort to improve access to health care services to all. PCC assists health care providers in keeping health care local and increasing quality services to underserved South Carolinians.

For more information, visit https://www.palmettocareconnections.org/.

About Advancements and DMG Productions:

Advancements is an information-based educational television series that explores recent developments taking place across several industries and economies. Shining a light on important issues and topics impacting society today, the series features the cutting-edge improvements, state-of-the-art technologies, and innovative solutions responsible for shaping, molding, and transforming our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming for viewers and networks.

For more information, please visit http://www.AdvancementsTV.com or call 866-496-4065.

Share article on social media or email:

Charlotte Chefs Unite to FORK Cancer


Dinner benefiting four Charlotte cancer non-profits

Culinary leaders are coming together on Thursday, September 7th at the UNC Charlotte Marriott to benefit FORK Cancer, a chef-driven dinner experience supporting four local cancer non-profits. This is the second annual event between Charlotte’s Food & Beverage Social Club and Forever Oceans.

During the event, guests will enjoy a four-course meal prepared by leading Charlotte Chefs, as well as wine, signature cocktails, and dancing. This celebration of life will support cancer survivors and help fund cancer education and research in the Charlotte community while honoring the legacy of those who have been affected by cancer, a disease which will touch 1.9 million Americans and their families this year. FORK Cancer’s four non-profit partners are Teal Diva (Gynecological Cancer), Xander’s Acts of Kindness Foundation (Pediatric Cancer), The Meggs Foundation (Young Adult Cancer), and Nothing Pink (Hereditary Breast and Ovarian Cancer).

Chef Mark Allison of Forever Oceans and founder of FORK Cancer was inspired by his own personal story in his vision for the event, “My beautiful wife Alison was diagnosed with stage-four Carcinoid Syndrome in 2008. Originally given three years to live, she courageously battled for eight years before passing away in 2015 at the age of 50. Not once did Alison complain about her condition or ask, “Why me?” She was such a driving force of inspiration. It has been eight years since she passed away and now is the time to help and support others in the same situation. Together, we can all make a difference in the lives of the people we love. FORK Cancer is a tribute to Alison and a celebration of life for all those affected by cancer.”

FORK Cancer tickets are $185 per person. Sponsor tables for eight guests are also available for purchase. FORK Cancer tickets can be purchased through F&B Social Club by clicking here:

https://buytickets.at/fbsocialclub/908260

About Food & Beverage Social Club

F&B Social Club partners with local restaurants, chefs and breweries to host multiple unique culinary experiences each month. F&B Social Club members connect over their love of fine food, drinks and social experiences while exploring the culinary scene of the Queen City.

About Forever Oceans

Forever Oceans is building the most sustainable, scalable, deep-water aquaculture platform on the planet—delivering premium, sashimi-grade fish to the world’s kitchens, ready to be prepared and served in any number of ways. Forever Oceans is changing the future of seafood while revitalizing the planet’s damaged oceans to provide a healthier future for all.

Contact

For more information about FORK Cancer, please contact Lucia Zats.

LZats@FBSocialClub.com

FBSocialClub.com

Share article on social media or email:

Moving Addiction ‘into the Spotlight,’ Local Addiction Professional Joins National Experts for Conference and Lobbying in Washington


News Image

Historically, addiction has been treated like a ‘personal’ or ‘private’ issue. But it affects every aspect of society.

Orange County resident and addiction treatment professional, Amber Vaughan, will attend the National Association of Addiction Treatment Providers (NAATP)’s annual conference and Hill Day in Washington May 21 to 23, 2023. Vaughan, who is the admissions director for Asana Recovery, a local addiction treatment program, will benefit from lectures by more than 30 of the nation’s leaders in the field of addiction treatment at the 44th Annual Addiction Leadership Conference, titled “Meeting the Challenges of Our Time.”

“I’m excited for the chance to learn from authorities in the field and to grow as a professional,” Vaughan says.

The schedule of presenters at the NAATP Leadership Conference includes top medical professionals and industry leaders in addiction treatment such as:

  • Ann Berger, MD, Chief of the Pain and Palliative Care Service at NIH Clinical Center
  • Neeru Bakshi, MD, FAPA, CEDS, Staff Psychiatrist at Headspace Health
  • Sam Bierman, Executive Director at Maryland Addiction Recovery Center
  • John Kelly, PhD, Elizabeth R. Spallin Professor of Psychiatry in Addiction Medicine at Harvard Medical School


The conference concludes with a public policy advocacy event where attendees will meet with members of Congress and other policy makers. Vaughan, along with the other NAATP Hill Day participants, will advocate for addiction education and treatment.

“Historically, addiction has been treated like a ‘personal’ or ‘private’ issue. But it affects every aspect of society,” Vaughan says. “Our elected leaders need to understand that fact. And our legislation should reflect it. I’m inspired to spur action in Congress to move the issue of addiction out of invisibility and into the spotlight.”

For more information about Amber Vaughan, visit asanarecovery.com/amber-vaughan/

For more information about NAATP or the 2023 conference, visit http://www.naatp.org.

Asana Recovery is recognized as one of the country’s top substance abuse treatment programs, leading the industry in providing successful outcomes through clinical excellence. Asana Recovery is fully accredited by the three top accrediting bodies in the United States and is certified by Legitscript. For more information on Asana Recovery’s addiction treatment program and services, visit http://www.asanarecovery.com

Share article on social media or email:

Arguments in Chemical Abortion Case Could Create Friction With Pro-Lifers


“Civil societies never see death as a solution to debates. All people are made in the image of God and ought to be treated with dignity commensurate with that truth. Societies that forget God fall headlong into self-destruction.”

On Wednesday, May 17, the U.S. 5th Circuit Court of Appeals is scheduled to hear arguments regarding the FDA’s illegal approval and subsequent deregulation of the lethal chemical abortion drug, Mifepristone. However, pro-life strategists are concerned the case could result from a response by the pro-abortion community, such as took place in March when arguments were heard at the 5th Circuit U.S. District Court. This was when a pro-life medical network in New York, CompassCare, was vandalized a second time. CompassCare CEO, Rev. Jim Harden, notified the FBI of concerns that the case would reignite a stir from the pro-abortion community.

Chemical abortion now represents over half of all abortion in the U.S. Overturning the FDA’s Clinton-era, fast-track approval of the drug would cut abortion in half overnight. This case would have a larger impact on the abortion landscape than even reversing Roe—a decision that sparked the prairie fire of violent pro-abortion recruitment and direct action against peaceful pro-life entities like CompassCare.

Rev. Harden notes, “Civil societies never see death as a solution to debates. All people are made in the image of God and ought to be treated with dignity commensurate with that truth. Societies that forget God fall headlong into self-destruction. Abortion and the rampant violence swirling among us should be taken as a fog horn warning the ship of state to avoid the shoals of godlessness and the resulting wickedness that will surely sink us.”

Share article on social media or email:

Beckman Foundation Announces 2023 Arnold O. Beckman Postdoctoral Fellows


This icon is in a hexagonal shape where the top third is in a royal blue with a white Erlenmeyer flask and the lower two-thirds is in white and features the words Beckman Postdoctoral Fellows 2015. The text is stacked and appears in black, then blue, then red and the word Beckman is in large block letters for emphasis.

Arnold O. Beckman Postdoctoral Fellows

The Arnold and Mabel Beckman Foundation announced today its 2023 class of Arnold O. Beckman Postdoctoral Fellows in Chemical Sciences, individuals who underscore the Foundation’s mission of supporting basic research in the chemical sciences and chemical instrumentation. They were selected after a three-part review led by a panel of scientific experts.

The Foundation will award more than $4.7 million in funding over the next three years for 16 exceptional research fellows from 11 universities and research institutions:

Chemical Instrumentation Development

  • Suman Gunasekaran, Ph.D., Cornell University

Chemical Sciences

  • Ashley Arcidiacono, Ph.D., The University of Chicago
  • Alexander Hurben, Ph.D., University of California, Berkeley
  • Christian Oswood, Ph.D., Massachusetts Institute of Technology
  • Clorice Reinhardt, Ph.D., Massachusetts Institute of Technology
  • Grigorii Skorupskii, Ph.D., Princeton University
  • Jakob Dahl, Ph.D., Massachusetts Institute of Technology
  • Jake Jagannathan, Ph.D., University of North Carolina at Chapel Hill
  • James Law, Ph.D., Massachusetts Institute of Technology
  • Jonathan Shultz, Ph.D., Duke University
  • Kelsie Wentz, Ph.D., Johns Hopkins University
  • Matthew Hannigan, Ph.D., New York University
  • Neil Razdan, Ph.D., Massachusetts Institute of Technology
  • Stephanie Hart, Ph.D., University of California, Berkeley
  • Steven Chapman, Ph.D., Northwestern University
  • Steven Chavez, Ph.D., Stanford University

“Congratulations to the 2023 class of Arnold O. Beckman Postdoctoral Fellows!” shared Dr. Anne Hultgren, Executive Director of the Arnold and Mabel Beckman Foundation. “We are inspired by their innovative chemistry and instrument development projects, and excited to provide this group of excellent scientists with support to help them transition to independent research careers.”

The Arnold O. Beckman Postdoctoral Fellowship provides salary and research support to postdoctoral scholars with the highest potential for success in an independent academic career in the chemical sciences, and to assist in their moves from mentored yet independent researchers to tenure-track positions. Funds for 2023 awardees will be issued this summer and extend over a period of up to three years.

About the Arnold and Mabel Beckman Foundation

Located in Irvine, California, the Arnold and Mabel Beckman Foundation supports researchers and nonprofit research institutions in making the next generation of breakthroughs in chemistry and the life sciences. Founded in 1978 by 20th century scientific instrumentation pioneer Dr. Arnold O. Beckman, the Foundation supports United States institutions and young scientists whose creative, high-risk, and interdisciplinary research will lead to innovations and new tools and methods for scientific discovery. For more information, visit http://www.beckman-foundation.org/.

###

Share article on social media or email:

Accelerating Gene Therapy for Ophthalmic Diseases, Upcoming Webinar Hosted by Xtalks


Basic research and clinical translation in ophthalmology face many difficulties, such as complicated operations, a long production period for experimental models and expensive equipment.

There are a large number of patients with hereditary ophthalmic diseases worldwide, with gene therapy drugs emerging as a powerful therapeutic tool in ophthalmology due to the limited efficacy of traditional treatments. As of 2021, ophthalmology ranks second in the gene therapy pipeline according to the number of treatments in development. There are many gene therapy drugs currently on the market, but basic research and clinical translation in ophthalmology face many difficulties, such as complicated operations, a long production period for experimental models and expensive equipment.

With the continuous progress of gene-editing technology and the development of new delivery methods, the future of gene therapy for ocular diseases is very promising. Despite the complicated operations, a long production period for experimental models and expensive equipment, companies and institutions are actively investing in research and development, and increasing numbers of clinical trials are being conducted to validate the safety and efficacy of these new treatments. The goal is to bring more effective and affordable treatments to patients with hereditary ophthalmic diseases and to improve their quality of life.

Register for this webinar to learn about the rapid advancements in preclinical ophthalmic gene therapy research, such as how AI-guided AAV design tools can help accelerate development of effective therapeutics to patients with ophthalmic diseases.

Join Joseph Wekselblatt, Senior Scientific Business Development Manager at Cyagen Biosciences, for the live webinar on Friday, June 9, 2023, at 1pm EDT (10am PDT).

For more information, or to register for this event, visit Accelerating Gene Therapy for Ophthalmic Diseases.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Marietta Dental Professionals, Announces that Three New Dentists Have Joined the Practice, Dr. Ray Cornay, Dr. Melissa Wendling and Dr. Vishal Patel


News Image

“Each one of these dentists brings a wealth of knowledge, unrivaled skill and unique experience to offer a wide variety of dental treatments and procedures,” says Dr. Dipesh Patel.

At Marietta Dental Professionals, they are dedicated to creating dream smiles in a responsible and conservative way. Patients can receive the dental care they need and deserve, ranging from preventative dental cleanings, Orthofx (clear aligners) to full-service dental implants.

Dr. Dipesh Patel and the team at Marietta Dental Professionals are thrilled to have these three elite dental professionals join the staff.

Dr. Melissa Wendling was born and raised in South Africa, and earned her DDM at Roseman University of Health Sciences in Utah. Dr. Wendling loves the combination of science and art that goes into dentistry. She is passionate about building strong relationships, educating her patients and helping them achieve their oral health goals.

Dr. Ray Cornay earned his DDM from the Dental College of Georgia at Augusta University and is a current member of the American Dental Association and the Georgia Dental Association. Dr. Cornay makes every effort to stay on top of current developments in dentistry. While his specialty is in complex reconstruction, Dr. Cornay’s scope of dental expertise includes procedures like tooth extractions, root canals, restorative crown and bridge treatments, veneers, removable dentures, orthodontics and dental implants. He is also board certified in moderate oral sedation to help patients overcome dental anxiety.

Dr. Vishal Patel, aka “Dr. V” earned his DDM from Tufts University School of Dental Medicine in Boston, MA. Dr. V spent 13 years practicing in Dallas, TX, and Raleigh, NC, before deciding to return home to Atlanta, GA.

Dr. V has taken many continuing education courses to keep up with the latest advancements and is always looking for the best products for his patients. Outside of routine general dentistry, his scope of practice includes endodontics, orthodontics (clear aligners), oral surgery, implants, laser dentistry and facial cosmetic dentistry, including Botox and dermal fillers. Dr. V is currently taking a 2-year course to become a certified holistic nutritionist & hoping to transfer this education into the field of dentistry.

“Each one of these dentists brings a wealth of knowledge, unrivaled skill and unique experience to offer a wide variety of dental treatments and procedures,” says Dr. Dipesh Patel.

More about Marietta Dental Professionals:

The clinic, conveniently located at 2551 Roswell Rd., Building 100 in Marietta, GA, is a state-of-the-art family dental practice that offers high-quality, modern dentistry in a comfortable, stress-free environment. The skilled dental team offers specialized treatments, such as smile makeovers, clear orthodontics, emergency dental care and more. Marietta Dental Professionals provides advanced dental technology, like 3D imaging and intraoral scanners, and the clinic offers relaxing amenities to keep patients comfortable at every step in the treatment process. For more information about the services offered at Marietta Dental Professionals, please visit http://www.mariettadentalpros.com or call (770) 514-5055.

Share article on social media or email:

Cannacore Group Expands Services to Psychedelic Markets in Oregon and Colorado


With a Team that has over 19+ years of combined knowledge and experience in regulated industries, Cannacore Group brings a unique and innovative perspective to each application as we have worked in various states from vertically integrated systems to individual licensing.

The Magic Mushroom’s Continuous Legalization Across the United States

In 2020, Oregon became to first state to legalize psilocybin for therapeutic purposes through [Measure 109, which was approved by a 55.75% majority vote. Due to the passage of the Psilocybin Program Initiative, licensed service providers are allowed to prescribe psilocybin products to patients 21 or older. Under the Oregon Health Authority’s framework, there are four (4) types of available licenses: (1) Service Center; (2) Manufacturer; (3) Facilitator; and (4) Psilocybin Testing Laboratory. Per the Oregon Psilocybin Services’ spring newsletter, there have been 11 applications submitted for Service Center licenses, 16 applications submitted for Manufacturer license, 27 applications submitted for Facilitator licenses, and 2 applications submitted for Laboratory licenses. Presently, only 2 licenses have been awarded thus far.

Two years after the City of Denver decriminalized the use of psilocybin for adults 21 and older, the state of Colorado passed Proposition 122 in 2022 to legalize psychedelics, specifically psilocybin for therapeutic uses in mental healthcare. The appointed Natural Medicine Advisory Board will make its first recommendations by September 30th for regulatory oversight, so clinics can begin offering psilocybin by late 2024. Due to its more expansive legislation, Proposition 122 further allows officials to develop similar programs by 2026 for other psychedelic substances like DMT, ibogaine, and mescaline (excluding peyote).

Although Oregon and Colorado are the only “legalized” markets presently, several other states and cities are beginning to not only decriminalize the use of psilocybin, but also expanding their research initiatives. Washington DC has decriminalized its use, as well as several cities within Michigan, Massachusetts, and Washington. Further, numerous states have either passed or initiated bills to promote research into the medical and potential of psilocybin for a variety of conditions. Such states include: Arizona, Hawaii, Missouri, Montana, New Hampshire, New Jersey, Utah, and more!

Who is Cannacore Group?

Cannacore Group is a team of experts with a passion for building successful businesses specializing in controlled substances from its initial start-up phase to a fully thriving operational business. From assisting our clients in identifying new markets to target to bringing in additional resources such as funding and an operational team from an expansive network, the Cannacore Group team works with clients side-by-side to ensure we can achieve their goals. Through extensive collaboration with clients across the United States, Cannacore Group has successfully supported marijuana businesses in 10+ states and have achieved an overall success rate of ~85%. Due to Cannacore Group’s work with legal markets from its initial onset, Cannacore Group has a deep understanding of the array of complex regulations that are key to obtaining a prosperous business license. As such, we are bringing our unique experiences and expert skillset garnered from working in highly regulated industries to the psychedelic markets in Oregon and Colorado to further assist innovative enterprises.

Founder/CEO, Paula Savchenko, Esq., has spent her career tailoring her services to each client’s individual needs. From liquor and tobacco licensing to cannabis business licensing, she has led the Cannacore Group in developing proven Standard Operating Procedures to ensure continuous success pre- and post-licensure. With a Team that has over 19+ years of combined knowledge and experience in regulated industries, Cannacore brings a unique and innovative perspective to each application as we have worked in various states from vertically integrated systems to individual licensing. Cannacore Group’s goal is to set our clients apart from the rest through strategic partnerships, foundational relationships with local partners and entities, and trailblazing community outreach and development.

How Can CannaCore Group Help You Achieve Your Goals in the Psychedelic Market?

To enter the legal psychedelic market, there are various regulatory requirements that are demanded by the state. Due to the relative similarity of the psychedelic licensing market and cannabis business licensing industry, the Cannacore Group team has an in-depth understanding of how to successfully meet all such requirements to ensure your team creates a strong, trusting relationship with the state’s regulatory body. Depending on your team’s needs, Cannacore Group offers an array of services to best meet your current and future goals. From building a team, including local partners and organizations, to introducing you to our network of lobbyists and expert industry professionals, we will make sure you have a strong group to enter such competitive markets. Further, Cannacore Group will provide proven Standard Operating Procedures and personalized narratives to ensure we represent your team as an efficient, turnkey group who is eager and ready to enter the industry. Cannacore Group will collaboratively develop innovative strategies to help differentiate your team from the rest through tactical funding, community outreach initiatives, and identifying ideal facilities.

With psilocybin legalization on the rise, Oregon has provided the initial template of what licensing for psychedelic businesses, specifically those still federally classified as a Schedule I drug, will look like. From residency ownership requirements to mandating locality approval, we will help your team overcome any and all regulatory requirements regardless of how each state adapts the process to their specific needs.

Contact Us Today!

Due to the novelty of the psychedelic market, we understand that having an expert Team behind you to overcome the complex regulatory obstacles is essential to ensuring your success. If you are interested in discussing your options, contact our Team today at mailto:info@cannacorgrp.com [info@cannacorgrp.com __title__ null] or via our website: https://www.cannacoregrp.com/contact/

We look forward to working with you!

Share article on social media or email:

AmeriCare Medical Honors Michigan’s Top Nurses at the 2023 Nightingale Awards


News Image

AmeriCare Medical, CEO, Greg Jamian with Post-Acute Care and Specialty Nursing Award winner, Mary Ross, BSN, RN

Greg Jamian, AmeriCare Medical, CEO, stated, “We are privileged to award Mary Ross, BSN, RN Children’s Hospital of Michigan, She has 35 years of service with 27 years of experience in ENT. Mary is proud of the support she provides to families with children who require tracheostomy. Thank you, Mary!”

Each year, AmeriCare Medical, Inc. and their home care company, AmeriStaff Nursing Services, partners with Oakland University – School of Nursing to sponsor this prestigious event. Greg Jamian, AmeriCare Medical, President and CEO, attended the ceremony and presented the award for Post-Acute Care and Specialty Nursing. Greg acknowledged, “We are privileged to award Mary Ross, BSN, RN from DMC – Children’s Hospital of Michigan (CHM), Mary has 35 years of service at CHM with 27 years of experience in Ears, Nose, and Throat (ENT). Mary is proud of the support she has provided families with children who require tracheostomy. Her compassion and dedication is truly inspiring!” Pamela Zawaszki, MBA, BSN, RN, HN-BC of Corewell Health was the runner-up for the Post-Acute Care Award.

Jamian also noted, “AmeriStaff Nursing Services is an exemplary employer of the nursing fields, and currently employs over 200 nurses and caregivers to Michigan businesses, hospitals, schools and assisted care facilities, including two thirds of AmeriStaff’s management team – who are alumni of the Oakland University’s School of Nursing.”

This year, there were nine Nightingale award winners and 123 nurses that were nominated throughout the State of Michigan. Oakland County Health Division was the evening’s big winner, capturing three Nightingales, while Henry Ford Health had the most nominations with thirty-six.

Since 1979, AmeriCare Medical, Inc. provides unmatched integrated healthcare services to hospitals, assisted care facilities and private homes throughout Michigan. AmeriCare Medical, Inc. is the parent company of AmeriStaff Nursing Services, OakMed Home Nursing and Rehabilitation, Private Reserve Home Care, Rx iV Pharmacy, and Sun Medical Equipment offering an easy solution for patients and all of their home care needs. For more information visit:http://www.americaremedical.com

Share article on social media or email:

Innovative Health to Discuss Cost and Environmental Savings of Device Reprocessing in Heart Rhythm 2023 Presentation


Device reuse (reprocessing) offers a way to reduce the percentage spent on devices, as well as environmental impact.

Innovative Health, Inc. today announced that it will be discussing the potential costs savings and environmental footprint reduction of a comprehensive device reuse (reprocessing) program during a poster session at this week’s Heart Rhythm 2023, the premier electrophysiology event presented annually by the Heart Rhythm Society. The presentation, entitled “Device Reuse And Atrial Fibrillation Ablation Procedure Costs As A Percentage of Reimbursement” (session title PO-454305, poster session II) will take place on May 20, 2023, from 1:30 p.m. to 3:30 p.m.

“Device costs in Atrial Fibrillation (AFib) ablation procedures are substantial and often more than half of CMS reimbursement, potentially cutting into profitability for EP labs,” said Innovative Health CEO Rick Ferreira. “At the same time, the extensive use of single-use devices in AFib ablation has negative impact on the environment. Device reuse (reprocessing) offers a way to reduce the percentage spent on devices, as well as environmental impact. We’re pleased to be shining a light on this incredible potential through this research presentation at Heart Rhythm 2023.”

Key findings of the study being presented by Innovative Health at HRS include:


  • Using reprocessed devices in an Atrial Fibrillation ablation procedure can reduce device costs by more than 30%, or approximately $3,250.
  • This savings reduces the device cost burden on reimbursement from 48% to 33%.
  • Using a reprocessed device reduces the carbon footprint of an electrophysiology device by 1.94 lbs. In an Atrial Fibrillation ablation procedure, the reduction in carbon emissions is estimated to be 13.6 lbs., or more than 2,000 lbs. per year for a facility that does 150 AFib ablations per year.

In addition to the poster session, you can visit Innovative Health at booth No. 533. You can also watch a short video about Rick Ferreira’s expectations for the conference or contact Innovative Health directly at HRS@innovative-health.com to set up a meeting.

About Innovative Health

Innovative Health is an advanced medical device reprocessing company that offers smarter utilization of medical devices in hospitals’ cardiology and electrophysiology programs.

Share article on social media or email: